Angela Mastronuzzi: Extremely important research on high-grade gliomas
Angela Mastronuzzi shared a post on LinkedIn:
“Very proud to present our published work and be a part of this extremely important research on high-grade gliomas, just out with Cancer Cell of Cell Press!
“GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant”
Highlights
– DHG-H3G34 follows a hierarchy along the interneuron lineage development continuum
– DHG-H3G34 tumor cells mirror spatial nests of normal human interneuron development
– Interneuron lineage progenitor states present a distinct vulnerability
– CDK6 is a promising clinically actionable target in DHG-H3G34.”
Authors: Ilon Liu et al.
Source: Angela Mastronuzzi/LinkedIn
Angela Mastronuzzi is pediatric hematologist-oncologist and the Head of Neuro-Oncology Unit at Bambino Gesù Children’s Hospital (Italy). She is also a professor at the UniCamillus International Medical University, and a Board Member of AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica). Her main fields of interest are CNS tumors and innovative therapies.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023